Invention Grant
- Patent Title: Glucagon-like peptide1 receptor agonists
-
Application No.: US16906063Application Date: 2020-06-19
-
Publication No.: US11655242B2Publication Date: 2023-05-23
- Inventor: David Andrew Coates , Todd Fields , Joseph Daniel Ho , Fucheng Qu
- Applicant: Eli Lilly and Company
- Applicant Address: US IN Indianapolis
- Assignee: Eli Lilly and Company
- Current Assignee: Eli Lilly and Company
- Current Assignee Address: US IN Indianapolis
- Agent Thomas Weber
- Main IPC: C07D405/14
- IPC: C07D405/14 ; A61P3/10 ; A61K9/00
Abstract:
In an embodiment, the present invention provides a compound of the formula:
or a pharmaceutically acceptable salt thereof, and methods of using this compound for treating type II diabetes mellitus.
or a pharmaceutically acceptable salt thereof, and methods of using this compound for treating type II diabetes mellitus.
Information query
